Several cross-sectional studies on different ethnic groups have demonstrated a modest, but significant elevation of serum FGF21 in patients with non-alcoholic fatty liver disease (NAFLD)28, 29. This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatotic liver disease.